Ligustrazine inhibits B16F10 melanoma metastasis and suppresses angiogenesis induced by Vascular Endothelial Growth Factor

Biochemical and Biophysical Research Communications

Volumn 386, Issue 2, 2009, Pages 374-379

  Chen, Lei ^a   Lu, Yin ^a   Wu, Jia ming ^a   Xu, Bo ^a   Zhang, Li juan ^a   Gao, Ming ^a   Zheng, Shi zhong ^a   Wang, Ai yun ^a   Zhang, Chang bin ^a   Zhang, Wei wei ^a   Lei, Na ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Angiogenesis; Ligustrazine; Tumor metastasis; VEGF

Indexed keywords

CD34 ANTIGEN; MATRIGEL; TETRAMETHYLPYRAZINE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MELANOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULAR RING;

ANGIOGENESIS INHIBITORS; ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; FIBROBLASTS; HUMANS; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICROVESSELS; NEOVASCULARIZATION, PATHOLOGIC; PYRAZINES; RATS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS; RATTUS;

EID: 67649439052     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.06.042     Document Type: Article

References (25)

1. Bicknell R., and Harris A.L. Mechanisms and therapeutic implications of angiogenesis. Curr. Opin. Oncol. 8 (1996) 60-65
2. Fidler I.J., and Ellis L.M. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79 (1994) 185-188
3. Folkman J. What is the evidence that tumours are angiogenesis dependent?. J. Nutl. Cancer Inst. 82 (1990) 4-6
4. Hart I.R., and Saini A. Biology of tumour metastasis. Lancet 339 (1992) 1453-1457
5. Ruoslahti E. Specialization of tumour vasculature. Nat. Rev. Cancer 2 (2002) 83-90
6. Cao Y. Tumor angiogenesis and therapy. Biomed. Pharmacother. 59 Suppl 2 (2005) S340-S343
7. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other disease. Nature 406 (2000) 249-257
8. Fan T.P., Yeh J.C., Leung K.W., Yue P.Y., and Wong R.N. Angiogenesis: from plants to blood vessels. Trends Pharmacol. Sci. 27 (2006) 297-309
9. Kwan C.Y., Daniel E.E., and Chen M.C. Inhibition of vasoconstriction by tetramethylpyrazine, Does it act by blocking the voltage-dependent Ca channel. J. Cardiovasc. Pharmacol. 15 (1990) 157-162
10. Peng W., Hucks D., Priest R.M., Kan Y.M., and Ward J.P. Ligustrazine-induced endothelium-dependent relaxation in pulmonary arteries via an NO-mediated and exogenous l-arginine-dependent mechanism. Br. J. Pharmacol. 119 (1996) 1063-1071
11. Jaffe E.A., Nachman R.L., Becker C.G., and Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52 (1973) 2745-2756
12. Marin V., Kaplanski G., Gres S., Farnarier C., and Bongrand P. Endothelial cell culture: protocol to obtain and cultivate human umbilical endothelial cells. J. Immunol. Methods 254 (2001) 183-190
13. Gamble J.R., Matthias L.J., Meyer G., Kaur P., Russ G., Faull R., Berndt M.C., and Vadas M.A. Regulation of in vitro capillary tube formation by anti-integrin antibodies. J. Cell. Biol. 121 (1993) 931-943
14. Nicosia R.F., and Ottinetti A. Modulation of microvascular growth and morphogenesis by reconstituted basement membrane gel in three-dimensional cultures of rat aorta: a comparative study of angiogenesis in matrigel, collagen, fibrin, and plasma clot. In Vitro Cell Dev. Biol. 26 (1990) 119-128
15. Kim C.W., Lee H.M., Lee T.H., Kang C., Kleinman H.K., and Gho Y.S. Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. Cancer Res. 62 (2002) 6312-6317
16. Akhtar N., Dickerson E.B., and Auerbach R. The sponge/Matrigel angiogenesis assay. Angiogenesis 5 (2002) 75-80
17. Chirivi R.G., Garofalo A., Crimmin M.J., Bawden L.J., Stoppacciaro A., Brown P.D., and Giavazzi R. Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor. Int. J. Cancer 58 (1994) 460-464
18. Hirayama R., Hirokawa K., and Makinodan T. Change in the metastatic mode of B16 malignant melanoma in C57BL/6 mice with ageing and sex. IARC Sci. Publ. (1985) 85-96
19. O'Rourke K.I., Baszler T.V., Besser T.E., Miller J.M., Cutlip R.C., Wells G.A., Ryder S.J., Parish S.M., Hamir A.N., Cockett N.E., Jenny A., and Knowles D.P. Preclinical diagnosis of scrapie by immunohistochemistry of third eyelid lymphoid tissue. J. Clin. Microbiol. 38 (2000) 3254-3259
20. Ariazi E.A., Satomi Y., Ellis M.J., Haag J.D., Shi W., Sattler C.A., and Gould M.N. Activation of the transforming growth factor beta signaling pathway and induction of cytostasis and apoptosis in mammary carcinomas treated with the anticancer agent perillyl alcohol. Cancer Res. 59 (1999) 1917-1928
21. Bao S., Wu Q., Sathornsumetee S., Hao Y., Li Z., Hjelmeland A.B., Shi Q., McLendon R.E., Bigner D.D., and Rich J.N. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res. 66 (2006) 7843-7848
22. Hotchkiss K.A., Ashton A.W., Mahmood R., Russell R.G., Sparano J.A., and Schwartz E.L. Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center. Mol. Cancer Ther. 1 (2002) 1191-1200
23. McMahon G. VEGF receptor signaling in tumor angiogenesis. Oncologist 5 Suppl. 1 (2000) 3-10
24. Veikkola T., and Alitalo K. VEGFs, receptors and angiogenesis. Semin. Cancer Biol. 9 (1999) 211-220
25. Hanahan D., and Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86 (1996) 353-364